Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Hellings, PW; Fokkens, WJ; Orlandi, R; Adriaensen, GF; Alobid, I; Baroody, FM; Bjermer, L; Senior, BA; Cervin, A; Cohen, NA; Constantinidis, J; De, Corso, E; Desrosiers, M; Diamant, Z; Douglas, RG; Gane, S; Gevaert, P; Han, JK; Harvey, RJ; Hopkins, C; Kern, RC; Landis, BN; Lee, JT; Lee, SE; Leunig, A; Lund, VJ; Bernal-Sprekelsen, M; Mullol, J; Philpott, C; Prokopakis, E; Reitsma, S; Ryan, D; Salmi, S; Scadding, G; Schlosser, RJ; Steinsvik, A; Tomazic, PV; Van, Staeyen, E; Van, Zele, T; Vanderveken, O; Viskens, AS; Conti, D; Wagenmann, M.
The EUFOREA pocket guide for chronic rhinosinusitis.
Rhinology. 2023; 61(1):85-89
Doi: 10.4193/Rhin22.344
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Tomazic Peter Valentin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Chronic rhinosinusitis (CRS) is known to affect around 5 % of the total population, with major impact on the quality of life of those severely affected (1). Despite a substantial burden on individuals, society and health economies, CRS often remains underdiagnosed, under-estimated and under-treated (2). International guidelines like the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) (3) and the International Consensus statement on Allergy and Rhinology: Rhinosinusitis 2021 (ICAR) (4) offer physicians insight into the recommended treatment options for CRS, with an overview of effective strategies and guidance of diagnosis and care throughout the disease journey of CRS.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Rhinitis - diagnosis, therapy, epidemiology
-
Quality of Life - administration & dosage
-
Sinusitis - diagnosis, therapy, epidemiology
-
Hypersensitivity - administration & dosage
-
Chronic Disease - administration & dosage
-
Nasal Polyps - diagnosis, therapy